PhenomeX to Participate in Antibody Engineering & Therapeutics Europe 2023
/PRNewswire/ -- PhenomeX Inc. (Nasdaq: CELL), the functional cell biology company, today announced its participation in the Antibody Engineering & Therapeutics...
Source: prnewswire.com